Cognivive, Inc.
Cognivive, Inc. is a private digital neurotherapeutics company founded in 2017 that develops CogniviveVR, an adaptive virtual reality platform enabling stroke patients to self-administer evidence-based upper-extremity rehabilitation therapy at home. The company also targets broader neurological conditions including Alzheimer's and Parkinson's disease.
- Company typePrivate
- Founded2017
- HeadquartersDavis, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Cognivive, Inc. does
Cognivive, Inc. is a private digital neurotherapeutics company founded in 2017 and headquartered in Davis, California, that develops CogniviveVR, a fully-immersive virtual reality platform for at-home stroke rehabilitation. The platform delivers therapeutic games designed as commercial-quality video experiences that adapt their difficulty in real time based on each patient's performance, targeting neuroplasticity through intensive, repetitive upper-extremity exercises. Treatment modules are evidence-based, drawing on what the company describes as decades of underlying scientific research, and are positioned as digital medicines that patients can self-administer after leaving clinical settings. The company explicitly identifies the extension of rehabilitation beyond the clinic walls as the core problem being solved.
Cognivive operates a hybrid go-to-market: an enterprise field-sales motion with a 'Schedule a Demo' call-to-action targeting healthcare providers and rehabilitation facilities, paired with a direct-to-consumer at-home distribution channel that allows stroke patients to access VR therapy independently. Revenue is generated via subscription-based access to the VR therapeutic software, although pricing is not publicly disclosed. The primary customer segment is stroke rehabilitation patients needing post-clinic therapy, with a secondary segment comprising patients with broader neurological conditions including Alzheimer's and Parkinson's disease.
Operationally, Cognivive remains an early-stage company with 1–10 employees, no disclosed institutional venture capital, and approximately $845,000 in cumulative disclosed funding across 2017–2020. Leadership consists of CEO Tony Simon and Joseph Salisbury as Head of Digital Therapeutics. The product targets a large addressable market — global digital health in neurology estimated at $38 billion in 2024 and projected to grow to $296.3 billion by 2034 — but as of the available data, the company has no disclosed FDA clearance, no named enterprise customers, no patents, and no formal strategic partnerships, making it a pre-commercial-stage platform with significant clinical validation and go-to-market execution ahead.
Cognivive, Inc. firmographics
Firmographics- Name
- Cognivive, Inc.
- Legal name
- Cognivive, Inc.
- Website
- https://cognivive.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cognivive, Inc. is a private digital neurotherapeutics company founded in 2017 that develops CogniviveVR, an adaptive virtual reality platform enabling stroke patients to self-administer evidence-based upper-extremity rehabilitation therapy at home. The company also targets broader neurological conditions including Alzheimer's and Parkinson's disease.
- Ownership category
- akta.pro rank
Cognivive, Inc. industry classification
Industry- Product category
- Digital Therapeutics
- NAICS
- Home Health Care Services (62161), Software Publishers (5132)
- SIC
- Services-Home Health Care Services (8082), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Neurological Rehabilitation Therapy In-Home (e.g., Stroke, Parkinson’s) (HSABADAE)
Keywords
Where Cognivive, Inc. is headquartered
LocationHeadquarters
- HQ city
- Davis
- HQ country
- United States
- HQ region
- North America
Markets served
Cognivive, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- VR Therapeutic Software Subscription: Cognivive generates revenue through subscription-based access to its VR therapeutic games and treatment modules, delivered as digital medicines for at-home stroke rehabilitation. The model supports long-term patient adherence with progressive difficulty scaling as patients' abilities improve.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Cognivive, Inc. product offering
Product offeringCore offering
Cognivive develops and sells CogniviveVR, a fully-immersive virtual reality therapeutic platform that enables stroke patients to self-administer rehabilitation therapy at home. The platform delivers adaptive treatment games whose challenge level continuously adjusts in real time to each patient's performance, targeting neuroplasticity through intensive, repetitive upper extremity exercises. Therapeutic activities are designed with commercial-quality video game aesthetics to drive intrinsic motivation and long-term adherence, positioning the product as a digital medicine.
Product overview
Cognivive offers a single unified therapeutic platform centered on CogniviveVR, an immersive virtual reality system for stroke rehabilitation. The platform provides personalized at-home therapy through adaptive VR games that adjust difficulty in real time based on patient performance, targeting neuroplasticity via repetitive upper extremity exercises. The product is designed as a digital medicine solution with commercial-quality video game aesthetics to promote patient engagement and long-term adherence.
Differentiator
Problem solved
Functional benefit
Brands
- CogniviveVR: Virtual reality therapeutic product line for stroke rehabilitation treatment games designed for patients to use at home.
Products and services
- CogniviveVR A fully-immersive virtual reality therapeutic platform that enables stroke patients to self-administer rehabilitation therapy at home. It delivers adaptive treatment games whose challenge level continuously adjusts in real time to each patient's performance, targeting neuroplasticity through intensive, repetitive upper extremity exercises. The product is positioned as a digital medicine and is sold via subscription-based access.
Quantifiable outcome
- Facilitates neuroplasticity through greater intensity and repetition of targeted upper extremity exercises
Companies that use Cognivive, Inc.
Customer profileSegments2 records
Ideal customer profiles2 records
Cognivive, Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Cognivive, Inc. partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Cognivive, Inc. competitors and assessment
Company assessmentDirect peers
- Neuro Rehab VR: Neuro Rehab VR builds VR-based therapy exercises for physical and occupational therapy in clinical and home settings, directly overlapping Cognivive's stroke rehabilitation focus.
- MindMaze: MindMaze develops immersive VR-based platforms for neurological recovery, including stroke and brain-injury rehabilitation, making it a direct competitor to Cognivive in adaptive VR neuro-rehabilitation.
- Penumbra (REAL Immersive System): Penumbra's REAL System is a clinically validated VR platform for upper and lower extremity rehabilitation in stroke and other neurological conditions, directly competing with CogniviveVR in clinical rehab settings.
- Constant Therapy Health: Constant Therapy Health offers a digital neurotherapy platform with adaptive cognitive and speech exercises for stroke and TBI recovery, providing a directly comparable digital neurotherapeutic model.
Broad incumbents
- Saebo: Saebo is an established provider of stroke rehabilitation products and clinical education, addressing the same patient population and therapy continuum as Cognivive but with a broader portfolio of physical rehab devices.
- XRHealth: XRHealth operates a VR-based telehealth therapy platform across multiple neurological and mental health indications, competing with Cognivive in VR neurotherapeutic delivery and remote patient monitoring.
- AppliedVR: AppliedVR develops FDA-authorized VR therapeutics, primarily for chronic pain, with a digital-therapeutic regulatory and commercialization approach comparable to Cognivive's pathway.
- NeuroPace: NeuroPace is an established neurotechnology company offering the RNS System for epilepsy, addressing adjacent neurological populations with regulated digital/neuro device offerings similar to Cognivive's regulatory ambitions.
Emerging players
- BehaVR: BehaVR builds immersive VR therapeutics for mental health and behavioral conditions, sharing Cognivive's VR-as-digital-medicine model while focusing on a different therapeutic vertical.
- Limbic: Limbic uses AI-driven personalization for mental health and rehabilitation applications, sharing the adaptive, data-driven therapy approach that Cognivive applies to stroke rehab.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Cognivive, Inc. social profiles
Digital presenceCognivive, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cognivive, Inc. leadership team
Management profileNumber of profiles
Profiles2 records
Cognivive, Inc. funding detail
Funding detailFunding overview
Funding rounds4 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cognivive, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cognivive, Inc.
What does Cognivive, Inc. do?
Cognivive develops and sells CogniviveVR, a fully-immersive virtual reality therapeutic platform that enables stroke patients to self-administer rehabilitation therapy at home. The platform delivers adaptive treatment games whose challenge level continuously adjusts in real time to each patient's performance, targeting neuroplasticity through intensive, repetitive upper extremity exercises. Therapeutic activities are designed with commercial-quality video game aesthetics to drive intrinsic motivation and long-term adherence, positioning the product as a digital medicine.
Is Cognivive, Inc. a public or private company?
Cognivive, Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cognivive, Inc. founded?
Cognivive, Inc. was founded in 2017. It employs 1 to 10 people.
Where is Cognivive, Inc. based?
Cognivive, Inc. is headquartered in Davis, United States, in the North America region.
How does Cognivive, Inc. make money?
One revenue line is on record: VR Therapeutic Software Subscription.
Who are Cognivive, Inc.'s main competitors?
Direct peers on record are Neuro Rehab VR, MindMaze, Penumbra (REAL Immersive System) and Constant Therapy Health. Broad incumbents are Saebo, XRHealth, AppliedVR and NeuroPace. Emerging players are BehaVR and Limbic.
Does Cognivive, Inc. have an API?
No public API is recorded for Cognivive, Inc..
What industry is Cognivive, Inc. in?
Cognivive, Inc.'s product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 62161 and its SIC code is 8082.